About
Ana Anderson is the Albert H. Coons Associate Professor of Neurology at Harvard Medical School, a Senior Scientist at Brigham and Women’s Hospital, an Institute Member of the Broad Institute of MIT and Harvard, and core faculty at the Gene Lay Institute of Immunology and Inflammation. Her research focuses on immune checkpoint receptors like Tim-3, LAG-3, and TIGIT in regulating T cell responses in cancer and autoimmunity.
- Current affiliations: Harvard Medical School, Brigham and Women’s Hospital, Broad Institute, Gene Lay Institute.
- Research areas: T cell dysfunction in cancer, tumor microenvironment, immune checkpoint blockade, neuro-immunology.
Her lab pioneered studies on Tim-3’s role in tumor-induced T cell exhaustion and uses cutting-edge technologies such as CyTOF, single-cell transcriptomics, and CRISPR/Cas9 to dissect molecular mechanisms. Recent work explores bi-specific antibodies, metabolic regulation via IL-18, and sex chromosomal influences on autoimmunity.
Dr. Anderson has published over 55 original papers, 19 reviews, and 5 book chapters. She serves on editorial boards for OncoImmunology and The Journal for Immunotherapy of Cancer, and advises companies including Tizona Therapeutics and Compass Therapeutics.
